Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 25, 2018
Reporting Period: The filing announces financial results for the three and nine months ended September 30, 2018.
Key Financial Metrics
The provided text is a cover sheet for a Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, no numerical values for these metrics are available in the source text.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It only indicates that such results were announced via a press release.
Guidance, Outlook, and Management Commentary
Management Action: On October 25, 2018, the company issued a press release and scheduled a conference call for 4:30 PM EST to discuss the results.
Legal Disclaimer: The information in Item 2.02 and the attached press release is furnished but not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the three and nine months ended September 30, 2018.
- Verify year-over-year growth rates and margin trends detailed in the press release.
- Check the conference call transcript (if available) for management commentary on future guidance and operational risks.
- Confirm the status of the company's liquidity and debt obligations as disclosed in the full financial statements referenced in the press release.